Role of olmesartan in ameliorating diabetic nephropathy in rats by targeting the AGE/PKC, TLR4/P38-MAPK and SIRT-1 autophagic signaling pathways
Author:
Funder
National Research Centre
Publisher
Elsevier BV
Subject
Pharmacology
Reference56 articles.
1. Olmesartan attenuates type 2 diabetes-associated liver injury: cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways;Abo El-Nasr;Eur. J. Pharmacol.,2020
2. Escitalopram ameliorates cardiomyopathy in type 2 diabetic rats via modulation of receptor for advanced glycation end products and its downstream signaling cascades;Ahmed;Front. Pharmacol.,2020
3. Role of angiotensin‐(1‐7) on renal hypertrophy in streptozotocin-induced diabetes mellitus open access;Amato;Pharmacol. Pharm.,2016
4. Suppression of SIRT1 in diabetic conditions induces osteogenic differentiation of human vascular smooth muscle cells via RUNX2 signalling;Bartoli-Leonard;Sci. Rep.,2019
5. The role of transforming growth factor-beta in diabetic nephropathy;Braga Gomes;Int. J. Med. Genet.,2014
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Rapid, Sensitive, and High-throughput Method for the Simultaneous Determination of Antihypertensive Drug Combinations in Dog Plasma by UHPLC-MS/MS: The Assessment of Predicable Bioequivalence of In-vitro Dissolution Condition;Current Pharmaceutical Design;2024-09
2. Roles of Sirt1 and its modulators in diabetic microangiopathy: A review;International Journal of Biological Macromolecules;2024-04
3. From Hypertension to Beyond: Unraveling the Diverse Mechanisms of Olmesartan in Disease Modulation;Drug Research;2024-02-13
4. Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway;Phytomedicine;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3